OBJECTIVES: To evaluate older adult emergency department (ED) patients for depression and cognitive impairment and to re-evaluate those findings 2 weeks later. DESIGN: Prospective cohort study. SETTING: ED. PARTICIPANTS: One thousand two hundred six older community-dwelling ED patients consented to participate; 811 (67%) completed the 2-week follow-up. MEASUREMENTS: Screening for depression (9-item Patient Health Questionnaire) and cognitive impairment (Six-Item Screener) was performed. Changes were evaluated through paired comparisons. RESULTS: At 2-week follow-up, for depression, 27 of 97 (28%) with baseline positive tests remained positive, and 22 of 706 (3%) with baseline negative tests were positive. At 2-week follow-up, for cognitive impairment, five of 43 (12%) with baseline positive tests remained positive, and 11 of 765 (1%) with baseline negative tests were positive. CONCLUSION: Significant variability exists for depression and cognitive impairment testing completed during and after the ED visit, with markedly fewer subjects testing positive at follow-up. The variability may reflect changes in clinical state, confounding from other conditions, or poor validity of the instruments in the ED setting. Further studies are needed to explain these findings before case-finding for these conditions is implemented in the ED setting.
OBJECTIVES: To evaluate older adult emergency department (ED) patients for depression and cognitive impairment and to re-evaluate those findings 2 weeks later. DESIGN: Prospective cohort study. SETTING: ED. PARTICIPANTS: One thousand two hundred six older community-dwelling ED patients consented to participate; 811 (67%) completed the 2-week follow-up. MEASUREMENTS: Screening for depression (9-item Patient Health Questionnaire) and cognitive impairment (Six-Item Screener) was performed. Changes were evaluated through paired comparisons. RESULTS: At 2-week follow-up, for depression, 27 of 97 (28%) with baseline positive tests remained positive, and 22 of 706 (3%) with baseline negative tests were positive. At 2-week follow-up, for cognitive impairment, five of 43 (12%) with baseline positive tests remained positive, and 11 of 765 (1%) with baseline negative tests were positive. CONCLUSION: Significant variability exists for depression and cognitive impairment testing completed during and after the ED visit, with markedly fewer subjects testing positive at follow-up. The variability may reflect changes in clinical state, confounding from other conditions, or poor validity of the instruments in the ED setting. Further studies are needed to explain these findings before case-finding for these conditions is implemented in the ED setting.
Authors: Kimberly S H Yarnall; Kathryn I Pollak; Truls Østbye; Katrina M Krause; J Lloyd Michener Journal: Am J Public Health Date: 2003-04 Impact factor: 9.308
Authors: Manish N Shah; Jeffrey J Bazarian; E Brooke Lerner; Rollin J Fairbanks; William H Barker; Peggy Auinger; Bruce Friedman Journal: Acad Emerg Med Date: 2007-05 Impact factor: 3.451
Authors: Kevin M Terrell; Fredric M Hustey; Ula Hwang; Lowell W Gerson; Neil S Wenger; Douglas K Miller Journal: Acad Emerg Med Date: 2009-03-30 Impact factor: 3.451
Authors: Christopher M Callahan; Frederick W Unverzagt; Siu L Hui; Anthony J Perkins; Hugh C Hendrie Journal: Med Care Date: 2002-09 Impact factor: 2.983
Authors: Jürgen Unützer; Wayne Katon; Christopher M Callahan; John W Williams; Enid Hunkeler; Linda Harpole; Marc Hoffing; Richard D Della Penna; Polly Hitchcock Noel; Elizabeth H B Lin; Lingqi Tang; Sabine Oishi Journal: J Am Geriatr Soc Date: 2003-04 Impact factor: 5.562
Authors: Richard T Griffey; Andrew T Melson; Margaret J Lin; Christopher R Carpenter; Melody S Goodman; Kimberly A Kaphingst Journal: Acad Emerg Med Date: 2014-02 Impact factor: 3.451
Authors: Lukas Faessler; Alexander Kutz; Sebastian Haubitz; Beat Mueller; Pasqualina Perrig-Chiello; Philipp Schuetz Journal: BMC Emerg Med Date: 2016-08-24